VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹9.18 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹-15 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹26 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.18 Cr | -68.35 | |
| Mar2024 | ₹29 Cr | Positive | |
| Mar2023 | ₹-15 Cr | Negative | |
| Mar2022 | ₹15 Cr | -42.89 | |
| Mar2021 | ₹26 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,483.6 Cr | -0.1% | 63% | 285% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -0.1% |
63% |
285% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses